|
|
The relationship between coronavirus and eye diseases |
YANG Bei1, HUO Junfeng2 |
1. Baotou Central Hospital, Department of Ophthalmology, Baotou 014040, China;
2. Baotou Central Hospital, Department of Oral and Maxillofacial Surgery, Baotou 014040, China |
|
|
Abstract: The human coronaviruses were isolated for the first time in the 1960s. The human coronaviruses OC43 and 229E were found as early as in 1966 and in 1967, but it was not until the SARS broke out in the world in 2003 that the coronaviruses came to a wide concern. This paper reviews the characteristics of the human coronavirus infection and the relationship with ocular diseases. It is hoped that ophthalmologists may help to screen the cases.
|
Received: 17 February 2020
|
|
|
|
[1] Masters P S, Coronoviridae P S. In:Fields virology(Sixth Edition)[M]. Philadelphia:Lippincott Williams & Wilkins, 2013.
[2] Woo P C, Lau S K, Tsoi H W, et al. Relative rates of non-pneumonic SARS coronavirus infection and SARS coronavirus pneumonia[J]. Lancet, 2004, 363(9412):841-845.
[3] Arden K E, Nissen M D, Sloots T P, et al. New human coronavirus, HCoV-NL63, associated with severe lower respiratory tract disease in Australia[J]. Journal of Medical Virology, 2005, 75(3):455-462.
[4] Woo P C Y, Lau S K P, Chu C, et al. Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia[J]. Journal of Virology, 2005, 79(2):884-895.
[5] Huynh J, Li S, Yount B, et al. Evidence supporting a zoonotic origin of human coronavirus strain NL63[J]. Journal of Virology, 2012, 86(23):12816-12825.
[6] To K K W, Hung I F N, Chan J F W, et al. From SARS coronavirus to novel animal and human coronaviruses[J]. Journal of Thoracic Disease, 2013, 5(Suppl 2):S103.
[7] Loon S C, Teoh S C B, Oon L L E, et al. The severe acute respiratory syndrome coronavirus in tears[J]. British Journal of Ophthalmology, 2004, 88(7):861-863.
[8] 金明, 仝小林, 赵世萍, 等. SARS患者的眼部症状观察[J] 中日友好医院学报, 2004, 18(1):28-30.
[9] Chan W M, Yuen K S C, Fan D S P, et al. Tears and conjunctival scrapings for coronavirus in patients with SARS[J]. British Journal of Ophthalmology, 2004, 88(7):968-969.
[10] 崔巍, 格日勒图, 高伟, 等. 传染性非典型肺炎患者泪液和血液中特异性抗体检测的对比研究[J]. 内蒙古医学杂志, 2004, 36(8):577-578.
[11] Tong T R, Lam B H, Ng T, et al. Conjunctiva-upper respiratory tract irrigation for early diagnosis of severe acute respiratory syndrome[J]. Journal of Clinical Microbiology, 2003, 41(11):5352-5352.
[12] Ren L, Gonzalez R, Xu J, et al. Prevalence of human coronaviruses in adults with acute respiratory tract infections in Beijing, China[J]. Journal of Medical Virology, 2011, 83(2):291-297.
[13] Gaunt E R, Hardie A, Claas E C J, et al. Epidemiology and clinical presentations of the four human coronaviruses 229E, HKU1, NL63, and OC43 detected over 3 years using a novel multiplex real-time PCR method[J]. Journal of Clinical Microbiology, 2010, 48(8):2940-2947.
[14] Ahmad S R, Bhutta Z A. A survey of paediatric prescribing and dispensing in Karachi[J]. Journal of the Pakistan Medical Association, 1990, 40(6):126-30.
[15] Cui L J, Zhang C, Zhang T, et al. Human coronaviruses HCoV-NL63 and HCoV-HKU1 in hospitalized children with acute respiratory infections in Beijing, China[J]. Advances in Virology, 2011, doi:101155/2022/129134.
[16] Cabeça T K, Bellei N. Human coronavirus NL-63 infection in a Brazilian patient suspected of H1N12009 influenza infection:description of a fatal case[J]. Journal of Clinical Virology, 2012, 53(1):82-84.
[17] Oosterhof L, Christensen C B, Sengelov H. Fatal lower respiratory tract disease with human coronavirus NL63 in an adult haematopoietic cell transplant recipient[J]. Bone Marrow Transplant, 2010, 45(6):1115-1116.
[18] Zhou W, Wang W, Wang H, et al. First infection by all four non-severe acute respiratory syndrome human coronaviruses takes place during childhood[J]. BMC Infectious Diseases, 2013, 13(1):433.
[19] Gorse G J, Patel G B, Vitale J N, et al. Prevalence of antibodies to four human coronaviruses is lower in nasal secretions than in serum[J]. Clin Vaccine Immunol, 2010, 17(12):1875-1880.
[20] Ahmad K. New human coronavirus isolated[J]. The Lancet Infectious Diseases, 2004, 4(5):255.
[21] Vabret A, Mourez T, Dina J, et al. Human coronavirus NL63, France[J]. Emerging Infectious Diseases, 2005, 11(8):1225.
[22] Chan J F W, Kok K H, Zhu Z, et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan[J]. Emerging Microbes & Infections, 2020, 9(1):221-236.
[23] 靳英辉, 蔡林, 程真顺, 等. 新型冠状病毒(2019-nCoV)感染的肺炎诊疗快速建议指南(标准版)[J]. 解放军医学杂志, 2020; 45(1):1-21.
[24] Xia J, Tong J, Liu M, et al, Evaluation of coronavirus in tears and conjunctival secretions of patients with SARSCoV-2 infection[J]. Journal of Medical Virology, 2020, doi:10.1002/jmv.25725.
[25] Schwartz D A, Graham A L. Potential maternal and infant outcomes from (Wuhan) coronavirus 2019-nCoV infecting pregnant women:Lessons from SARS, MERS, and other human coronavirus infections[J]. Viruses, 2020, 12(2):194.
[26] 刘家琦, 李凤鸣. 实用眼科学(第二版)[M]. 北京:人民卫生出版社, 2010:286.
[27] 杨贵波, 邵一鸣. 粘膜免疫与艾滋病的预防和控制[J]. 中国艾滋病性病, 2006, 12(5):472-476.
[28] 杨贵波, 邵一鸣. 人类免疫缺陷病毒与粘膜免疫[J]. 世界华人消化杂志, 2005, 13(14):1750-1759.
[29] 程秋兰. 血溅入结膜传播丙型肝炎病毒[J]. 国外医学:流行病学传染病学分册, 1994:21(1):38.
[30] Lian K Y, Napper G, Stapleton F J, et al. Infection control guidelines for optometrists 2016[J]. Clinical and Experimental Optometry, 2017, 100(4):341-356. |
[1] |
RUAN Mei, WANG Yang, WANG Qian. Analysis of trends and topics of global research on coronavirus[J]. Science & Technology Review, 2020, 38(4): 6-14. |
[2] |
LI Fu. Clinical diagnosis, treatment and epidemiological study of novel coronavirus pneumonia[J]. Science & Technology Review, 2020, 38(4): 15-20. |
[3] |
CHEN Xuefeng, ZHANG Qin, ZHANG Leqi. American emergency management psychological service system and its enlightenment[J]. Science & Technology Review, 2020, 38(4): 77-85. |
[4] |
CHEN An, SHI Yu. The influence of risk preference on public purchase behavior: with the purchase of masks as an example[J]. Science & Technology Review, 2020, 38(4): 86-92. |
|
|
|
|